August 31, 2018 - When Bryan Mazlish’s son was diagnosed with Type I diabetes, there were unexpected challenges. Managing diabetes on a day-to-day basis was tough, so he hacked into his son’s insulin pump and continuous glucose monitor to create the world’s first ambulatory real-world artificial pancreas. Now his mission is to make it available to everyone.
November 15, 2017 - Dan Kendall's guest in this episode is Jeffrey Brewer, CEO and Co-founder of Bigfoot Biomedical. He shares his story of when he received the news that his son has diabetes, and the confusion and despair that followed. He explains how that led to changes in his life and took him down a path that has seen him start Bigfoot Biomedical. He gives insights into the tremendous progress they’ve made in a short space of time and what the future holds for his product, and, importantly, for people with insulin-dependent diabetes around the world.
October 17, 2017 - Bigfoot Biomedical is now partnering with Abbott to use the Libre in their automated insulin delivery system. We talk to CEO Jeffrey Brewer to find out how what this means and what’s on the horizon for Bigfoot.
October 6, 2017 - Jeffrey Brewer couldn’t accept the limits on technology when his son first was diagnosed with diabetes. Back in 2002, commercial airliners could almost land themselves and nuclear plants were automated. Yet the process of measuring glucose blood levels and injecting insulin were still determined by patients and families who were forced to do the math and administer the life-saving medicine themselves. That frustration pushed the start-up veteran into a career change – focusing his energy and efforts on treating diabetes.
August 10, 2016 - Bigfoot Biomedical came on the scene in 2014 determined to change the way companies look at diabetes technology. They’ve moved forward quickly and are now starting their first clinical trial for their “Smartloop” automated insulin delivery system. Stacey talks to Bigfoot Chief Engineer Lane Desborough about what this system is, what the trial is testing, and how you can find out if you’re eligible to enroll.
March 1, 2016 - Bigfoot Biomedical is a company dedicated to the development of a closed loop insulin delivery system. Founded and run by the parents and loved ones of people living with type 1 diabetes, Bigfoot has a personal investment in getting to market as soon as possible. Episode 49 is with Jeffrey Brewer, former CEO of the JDRF and current CEO of Bigfoot. The future isn't so far away.
February 9, 2016 - In 2013, Bryan Mazlish created a home-made artificial pancreas system for use by his wife and son, both of whom have type 1 diabetes. Because Mazlish preferred to stay anonymous, a reporter dubbed him “Bigfoot.” In 2015, Mazlish went public and partnered with two others to create Bigfoot Biomedical. Their goal is to bring this technology & other products to market in order to improve the lives of people with T1D. In our Community Connection, Stacey finds out about Hockey Fights T1D, a new JDRF fundraiser in upstate NY sparked by a two year old’s diagnosis.
November 10, 2015 - Host Chris Snyder: "This week I spoke with Jeffrey Brewer about weather in the Bay Area, his work at Kickstart, and his advocacy efforts within the JDRF including his stint as their CEO. Most importantly we discuss Bigfoot Biomedical, its origins, and its aspirations."
February 9, 2016 - Host Stacey Simms talks to Jeffrey Brewer, former head of JDRF, now CEO of Bigfoot Biomedical. We’ll find out how he hopes to simplify diabetes management through technology and the story behind the Bigfoot name.